2015重症医学回顾与展望
被引量:12
Critical Care Medicine breakthrough in 2015
摘要
2015年国际重症医学又有了新的进展,本文就临床研究的相关进展进行总结,供同道参考。
1严重脓毒症诊断标准的争议与“脓毒症3.0”
通过对2000年至2013年澳大利亚和新西兰172个重症加强治疗病房(ICU)近120万例患者的数据分析,Kaukonen等根据是否满足≥2条全身炎症反应综合征(SIRS)的诊断标准将感染伴器官功能衰竭的患者分为SIRS阳性和SIRS阴性两组,结果显示在近11万例感染伴器官功能衰竭的患者中,
出处
《中华危重病急救医学》
CAS
CSCD
北大核心
2016年第1期3-7,共5页
Chinese Critical Care Medicine
参考文献54
-
1Kaukonen KM, Bailey M, Pilcher D, et al. Systemic inflammatory response syndrome criteria in defining severe sepsis [J]. N Engl J Med, 2015, 372 (17): 1629-1638. DOI: 10.1056/NEJMoaI415236.
-
2Shankar-Hari M, Deutschman CS, Singer M. Do we need a new definition of sepsis? [J]. Intensive Care Med, 2015, 41 (5): 909-911. DOI: 10.1007/s00134-015-3680-x.
-
3Vellinga NA, Boerma EC, Koopmans M, et al. International study on microcirculatory shock occurrence in acutely ill patients [J]. Crit Care Med, 2015, 43 (1): 48-56. DOI: 10.1097/CCM. 0000000000000553.
-
4Casserly B, Phillips GS, Schorr C, et al. Lactate measurements in sepsis-induced tissue hypoperfusion: results from the Surviving Sepsis Campaign database [J]. Crit Care Med, 2015, 43 (3): 567- 573. DOI: 10.1097/CCM.0000000000000742.
-
5Mouncey PR, Osborn TM, Power GS, et al. Trial of early, goal-directed resuscitation for septic shock [J]. N Engl J Med, 2015, 372 (14): 1301-1311. DOI: 10.1056/NEJMoa1500896.
-
6黄伟,万献尧,孟玉兰,王宁.2014年重症医学回顾与展望[J].中华危重病急救医学,2015,27(1):3-9. 被引量:8
-
7Angus DC, Barnato AE, Bell D, et al. A systematic review and meta-analysis of early goal-directed therapy for septic shock: the ARISE, ProCESS and ProMISe Investigators [J]. Intensive Care Med, 2015, 41 (9): 1549-1560. DOI: 10.1007/s00134-015-3822-1.
-
8Gupta RG, Flartigan SM, Kashiouris MG, et al. Early goal-directed resuscitation of patients with septic shock: current evidence and future directions [J]. Crit Care, 2015, 19 : 286. DOI: 10.1186/ s13054-015-1011-9.
-
9Saugel B, Trepte C J, Heckel K, et al. Hemodynamic management of septic shock: is it time for "individualized goal-directed hemodynamic therapy" and for specifically targeting themicrocirculation? [J]. Shock, 2015, 43 (6): 522-529. DOI: 10.1097/ SHK.0000000000000345.
-
10Rhodes A, Phillips G, Beale R, et al. The Surviving Sepsis Campaign bundles and outcome: results from the International Multicentre Prevalence Study on Sepsis (the IMPreSS study) [J]. Intensive Care Med, 2015, 41 (9): 1620-1628. DOI: 10.1007/ s00134-015-3906-y.
二级参考文献259
-
1Shafer SL. Notice of retraction.Anesth Analg, 2010,111 : 1567.
-
2Hartog CS, Bauer M, Reinhart K. The efficacy and safety of colloid resuscitation in the critically ill. Anesth Analg,2011,112: 156-164.
-
3Hartog CS, Kohl M, Reinhart K. A systematic review of third-generation hydroxyethyl starch(HES 130/0.4) in resuscitation: safety not adequately addressed. Anesth Analg,2011,112 : 635-645.
-
4Hartog CS,Reuter D,Loesche W,et al. Influence of hydroxyethyl starch (HES) 130/0.4 on hemostasis as measured by viscoelastic device analysis : a systematic review. Intensive Care Med, 2011,37 : 1725-1737.
-
5Delaney AP, Dan A, McCaffrey J, et al. The role of albumin as a resuscitation fluid for patients with sepsis: a systematic review and meta-analysis. Crit Care Med, 2011,39 : 386-391.
-
6Crystalloid remus Hydroxyethyl Starch Trial (CHEST) Management Committee. The crystalloid versus hydroxyethyl starch trial: protocol for a multi-centre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality. Intensive Care Med, 2011,37 : 816-823.
-
7James MF, Michell WL, Joubert IA, et al. Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: the FIRST trial (Fluids in Resuscitation of Severe Trauma). Br J Anaesth, 2011,107 : 693-702.
-
8Boyd JH,Forbes J,Nakada TA,et al. Fluid resuscitation in septic shock : a positive fluid balance and elevated central venous pressure are ass~iated with increased mortality. Crit Care Med,2011,39: 259-265.
-
9Maitland K, Kiguli S, Opoka RO, et al. Mortality after fluid bolus in African children with severe infection. N Engl J Med, 2011,364: 2483-2495.
-
10Takala J, Ruokonen E, Tenhunen J J, et al. Early non-invasive cardiac output monitoring in hemodynamically unstable intensive care patients : a multi-center randomized controlled trial. Crit Care, 2011,15:R148.
共引文献28
-
1徐敏,孙运波,邢金燕.血必净注射液对内毒素刺激内皮祖细胞增殖和黏附功能的影响[J].中国中西医结合急救杂志,2012,19(4):223-225. 被引量:4
-
2赵京生,袁跃彬,胡波.243名部队卫生员止血、通气、抗休克技能的现况调查及干预研究[J].中国危重病急救医学,2012,24(8):499-500. 被引量:2
-
3黄伟,万献尧.重症医学2012回顾与展望[J].中华危重病急救医学,2013,25(1):8-13. 被引量:13
-
4陈杰,王明明,胡东军,叶忠亮,沈芝红,吕志刚,蔡云,祁洪刚.肾移植受者重症肺炎合并急性呼吸衰竭的临床研究[J].现代实用医学,2013,25(4):382-383. 被引量:1
-
5王东强,李银平,李志军,李桥茹,付鹏亮.老年多器官功能障碍综合征的中医证候探讨[J].中华危重病急救医学,2013,25(9):550-553. 被引量:8
-
6黄伟,万献尧.2013年重症医学回顾与展望[J].中华危重病急救医学,2014,26(1):3-10. 被引量:10
-
7彭怀斌.肾移植术后肺部感染的CT影像学特点[J].中国实用医刊,2014,41(4):103-103. 被引量:1
-
8杨万杰,秦英智.危重病患者液体治疗的进展[J].医学综述,2014,20(3):445-448. 被引量:2
-
9黄若兰,张忠,徐慕娟,常晓,乔秋杰,王玲,孟新科.四逆汤对脓毒症患者下丘脑-垂体-肾上腺轴的影响[J].中华危重病急救医学,2014,26(3):184-187. 被引量:11
-
10李志刚,刘丽君.贞芪扶正颗粒对重症患者感染预防及治疗的协同作用探讨[J].中国中西医结合急救杂志,2014,21(3):209-211. 被引量:9
同被引文献100
-
1刘丽君,彭建新,洪华珠,叶雯,乔媛媛.线粒体在细胞凋亡中的变化与作用[J].细胞生物学杂志,2005,27(2):117-120. 被引量:44
-
2朱雪琦,刘清泉,姚咏明.脓毒症动物模型制备方法的研究进展[J].中国危重病急救医学,2006,18(2):114-116. 被引量:30
-
3陈嘉屿,张方信,吴红梅,刘丽华,赵丽.连续血液滤过对重症急性胰腺炎的治疗作用[J].第四军医大学学报,2006,27(16):1496-1498. 被引量:12
-
4史艳晖,卢圣栋.转录因子NF-κB的研究现状及其应用前景[J].中国生物工程杂志,2007,27(4):110-114. 被引量:42
-
5Ornellas DS, Maron-Gutierrez T, Ornellas FM, et al. Early and late effects of bone marrow-derived mononuclear cell therapy on lung and distal organs in experimental sepsis [J]. Respir Physiol Neurobiol, 2011, 178 (2): 304-314. DOI: 10.1016/j.resp.2011.06.029.
-
6Tasaka S, Koh H, Yamada W, et al. Attenuation of endotoxin- induced acute lung injury by the Rho-associated kinase inhibitor, Y-27632 [J]. Am J Respir Cell Mol Biol, 2005, 32 (6): 504-510.
-
7DOI: 10.11 Cinel I, Ark M, Dellinger P, et al. Involvement of Rho kinase fROCK) in sepsis-induced acute lung injury [J]. J Thorac Dis, 2012, 4 (1): 30-39.
-
8Xie K, Wang W, Chen H, et al. Hydrogen-Rich Medium Attenuated Lipopolysaccharide-Induced Monocyte-Endothelial Cell Adhesion and Vascular Endothelial Permeability via Rho-Associated Coiled-Coil Protein Kinase [J]. Shock, 2015, 44 (1): 58-64.
-
9Chen H, Xie K, Han H, et al. Molecular hydrogen protects mice against polymicrobial sepsis by ameliorating endothelial dysfunction via an Nrf2/HO-1 signaling pathway [J]. Int Immunopharmacol, 2015, 28 (1): 643-654. DOI: 10.1016/j.intimp.2015.07.034.
-
10Xie K, Yu Y, Pei Y, et al. Protective effects of hydrogen gas on murine polymicrobial sepsis via reducing oxidative stress and I-IMGB 1 release [J]. Shock, 2010, 34 (1): 90-97. DOI: 10.1097/SI-IK. 0b013e3181.
引证文献12
-
1黄伟,秦永新.2018国际重症医学回顾与展望[J].中华危重病急救医学,2019,31(1):16-22. 被引量:8
-
2张红涛,刘玲玲,于洋,孙哲,梁禹,于泳浩.Rho/ROCK信号通路在氢气改善脓毒症小鼠急性肺损伤中的作用[J].中华危重病急救医学,2016,28(5):401-406. 被引量:9
-
3薄禄龙,卞金俊,邓小明.2016年脓毒症最新定义与诊断标准:回归本质重新出发[J].中华麻醉学杂志,2016,36(3):259-262. 被引量:110
-
4金善子,王胜.线粒体通透性转换孔在脓毒症心肌抑制发生过程中的作用[J].中华危重病急救医学,2016,28(8):747-751. 被引量:17
-
5曾鸣,张玉坤,吴永昌,江兵,刘丹.苦柯胺B通过抑制高迁移率族蛋白B1/核转录因子-κB信号通路减轻脓毒症小鼠肺损伤[J].中华危重病急救医学,2016,28(11):994-997. 被引量:7
-
6代晓明,黄伟.2016重症医学回顾与展望[J].中华危重病急救医学,2017,29(1):1-5. 被引量:13
-
7陈全福,杨荣源.从“道”“法”“术”3个层面看中西医结合重症医学的临床意义:从1例重度腹腔高压综合征合并MODS[J].中国中西医结合急救杂志,2017,24(1):3-5. 被引量:6
-
8吴华炼,王勇,黄瑞瑜,张晶晶,付成琴,权明桃.系统化早期康复运动对ICU机械通气患者肌力及自理能力的干预效果[J].广东医学,2017,38(8):1216-1219. 被引量:57
-
9黄伟.2017重症医学临床研究回顾与展望[J].中华危重病急救医学,2018,30(1):1-7. 被引量:14
-
10卢年芳,姜利,朱波,韩文勇,赵颖琦,师云涛,郭发爽,席修明.外周动脉峰流速变异度评估感染性休克患者容量反应性的临床研究[J].中华危重病急救医学,2018,30(3):224-229. 被引量:27
二级引证文献273
-
1沈婷.以护士为主导的多学科协作功能锻炼在预防ICU后综合征的效果分析[J].智慧健康,2022,8(25):218-222.
-
2周志剑,吴文清.重症超声评估下腔静脉内径变异度在感染性休克患者容量反应的应用价值[J].智慧健康,2020(25):20-22.
-
3李健.急诊脓毒症患者血清NT-pro BNP和β2-MG水平及临床意义[J].西藏医药,2021,42(6):72-74.
-
4鲍艳飞,吴智宏.校正左心室射血时间指导冠状动脉搭桥术围术期容量管理中的应用[J].心脑血管病防治,2020(3):263-266. 被引量:2
-
5彭鹏,邓婷,杨凯.脓毒症心功能障碍相关信号通路研究[J].实用休克杂志(中英文),2020(5):257-260. 被引量:1
-
6陈娟红,李飞,姚惠萍,潘洁琼.心脏术后患者早期目标导向活动管理方案的构建及应用[J].中华急危重症护理杂志,2020(5):455-458. 被引量:9
-
7魏秀玲,张培娟,周暄琳,董君丽,李冬梅.早期活动方案在高海拔地区神经外科术后患者中的应用效果分析[J].高原医学杂志,2022,32(1):42-45.
-
8廖春燕.ICU机械通气患者早期活动的研究进展[J].华夏医学,2020(3):190-194. 被引量:3
-
9蔡倩珂,陈二洋.基于任务导向的早期床边康复训练在ICU清醒患者中的应用观察[J].反射疗法与康复医学,2020(1):131-132.
-
10明旭,王秀.呼盟绿色食品开发再创佳绩[J].食品信息,2000(7):20-20.
-
1刘伟,史振伟.连续性血液净化治疗脓毒症的研究进展[J].中国临床医生杂志,2016,44(7):23-25. 被引量:12
-
2肾功能不良(肾衰竭)[J].国外科技资料目录(医药卫生),2001(12):101-101.
-
3喻文,罗红敏.肾脏替代治疗时机与患者预后:一项随机对照研究的再次分析[J].中华危重病急救医学,2016,28(3):266-266. 被引量:4
-
4慢性肾脏病4期患者早透析并不能改善生存[J].中国处方药,2010(8):8-8.
-
5施焕中(译).ICU鼻饲指南可以改善临床指标但不能提高生存率[J].英国医学杂志中文版,2009,12(2):95-95.
-
6杨扬,韩飞.类固醇可降低IgA肾病复发所致移植肾失功的风险[J].中华移植杂志(电子版),2011,5(3):62-62.
-
7赵日升,汪挺.腹腔镜辅助与开放直肠癌术后病理学结局的比较:ALaCaRT随机临床试验结果未能提供足够证据支持直肠癌常规应用腹腔镜手术[J].中华胃肠外科杂志,2016,19(1):53-53. 被引量:2
-
8杨昌山.胶体扩容剂可引起低血压或过敏反应[J].中国处方药,2006,5(8):68-68.
-
9阙斌.BRANCH研究入选第1例使用冠脉分叉支架患者[J].中国心血管病研究,2008,6(9):705-705.
-
10向SCI收录期刊投稿的常见问题[J].中国组织工程研究,2012,16(28).